Latest News About Adult Attention Deficit Hyperactivity Disorder

Here are the latest public updates on adult ADHD from reputable sources:

• News highlights and prevalence trends

  • Ontario, Canada saw a substantial rise in ADHD medication prescriptions from 2015 to 2023, with notable increases among adults and women, underscoring growing recognition and treatment of adult ADHD in real-world practice [system-sourced summary from recent health news outlets]. This reflects broader international trends of increasing ADHD recognition and pharmacotherapy use in adults [source: Ontario prescription data studies].
  • A large-scale synthesis of ADHD treatments continues to support medication (for both children and adults) and cognitive-behavioral therapy for adults as among the most effective approaches in the short term, with ongoing research into adjunctive and novel therapies [NIMH overview of current treatment landscape].

• Treatments and access

  • Newer treatment modalities under investigation include neurofeedback, cognitive training, mindfulness, and neuromodulation, with researchers comparing these approaches to standard pharmacotherapy and psychotherapy to identify which work best for specific symptoms or patient groups [NIMH ADHD page].
  • Access barriers, including wait times for diagnosis and care, have prompted primary-care–led screening programs and streamlined pathways that reduce time to treatment in some settings, particularly for uncomplicated adult ADHD [recent clinical reports].

• Diagnosis and patient experience

  • Increasing numbers of adults are being diagnosed with ADHD, highlighting a shift in recognition across adulthood and the importance of adult-focused assessment, with guidance emphasizing comprehensive evaluation and individualized treatment planning [National/academic syntheses and CHADD updates].

• Public health and policy context

  • Public health bodies and research consortia continue to monitor ADHD prevalence, treatment uptake, and health outcomes in adults, aiming to optimize outcomes through evidence-based interventions and accessible care pathways [NIMH and national academies summaries].

If you’d like, I can tailor updates to a specific region (e.g., Czech Republic, Europe, or the United States), or pull more detailed summaries from a particular source (e.g., NIMH, CHADD, or national health agencies). I can also provide a quick chart of recent trends (e.g., adult ADHD diagnoses and stimulant prescriptions) if you want a visual. Would you like me to do that?